Phase III Randomized Study Of Sorafenib Plus Doxorubicin Versus Sorafenib In Patients With Advanced Hepatocellular Carcinoma (HCC)- CALGB 80802 (Alliance)

Abou-Alfa, Ghassan K. ,  Niedzwieski, Donna ,  Knox, Jennifer J. ... -  ASCO GI   -  J. Clin. Oncol.   -  2016    

Abstract -  Primary -  Primary -  GI -  CALGB-80802